Tonix Pharma (TNXP) Says TNX-102 SL Phase 3 Did Not Meet Primary Endpoint in Fibromyalgia

Go back to Tonix Pharma (TNXP) Says TNX-102 SL Phase 3 Did Not Meet Primary Endpoint in Fibromyalgia
TONIX PHARM HLDG (NASDAQ: TNXP) Delayed: 1.99 --0 (-0%)
Previous Close $1.99    52 Week High $7.95 
Open $1.99    52 Week Low $0.40 
Day High $1.99    P/E N/A 
Day Low $1.99    EPS $-5.33 
Volume 8,893